keyword
https://read.qxmd.com/read/38652877/datopotamab-deruxtecan-in-advanced-or-metastatic-hr-her2-and-triple-negative-breast-cancer-results-from-the-phase-i-tropion-pantumor01-study
#1
JOURNAL ARTICLE
Aditya Bardia, Ian E Krop, Takahiro Kogawa, Dejan Juric, Anthony W Tolcher, Erika P Hamilton, Toru Mukohara, Aaron Lisberg, Toshio Shimizu, Alexander I Spira, Junji Tsurutani, Senthil Damodaran, Kyriakos P Papadopoulos, Jonathan Greenberg, Fumiaki Kobayashi, Hong Zebger-Gong, Rie Wong, Yui Kawasaki, Tadakatsu Nakamura, Funda Meric-Bernstam
PURPOSE: Datopotamab deruxtecan (Dato-DXd) is an antibody-drug conjugate consisting of a humanized antitrophoblast cell-surface antigen 2 (TROP2) monoclonal antibody linked to a potent, exatecan-derived topoisomerase I inhibitor payload via a plasma-stable, selectively cleavable linker. PATIENTS AND METHODS: TROPION-PanTumor01 (ClinicalTrials.gov identifier: NCT03401385) is a phase I, dose-escalation, and dose-expansion study evaluating Dato-DXd in patients with previously treated solid tumors...
April 23, 2024: Journal of Clinical Oncology
https://read.qxmd.com/read/38652858/comparison-of-safety-and-treatment-continuity-of-palbociclib-and-abemaciclib-for-hormone-receptor-positive-her2-negative-metastatic-recurrent-breast-cancer
#2
JOURNAL ARTICLE
Makiko Go, Michio Kimura, Shiori Yamada, Eiseki Usami, Yoshihiro Noguchi, Tomoaki Yoshimura
Background : Appropriate adverse event (AE) management and maintenance of therapeutic intensity are necessary to achieve therapeutic benefits of CDK4/6 inhibitors (palbociclib and abemaciclib) in hormone receptor-positive, HER2-negative metastatic/recurrent breast cancer. Objective : This study was aimed at clarifying the effect of AEs associated with palbociclib and abemaciclib on treatment. Methods : A total of 62 and 49 patients were prescribed palbociclib and abemaciclib, respectively, at our hospital from January 1, 2018 to June 30, 2023...
April 23, 2024: Journal of Pharmacy Practice
https://read.qxmd.com/read/38652803/apparent-mineralocorticoid-excess-in-israel-a-case-series-and-literature-review
#3
JOURNAL ARTICLE
Asaf Lebel, Efrat Ben Shalom, Rozan Mokatern, Raphael Halevy, Yoav Zehavi, Daniela Magen
BACKGROUND AND OBJECTIVE: Apparent mineralocorticoid excess (AME) syndrome is an ultra-rare autosomal-recessive tubulopathy, caused by mutations in HSD11B2, leading to excessive activation of the kidney mineralocorticoid receptor, and characterized by early-onset low-renin hypertension, hypokalemia, and risk of chronic kidney disease (CKD). To date, most reports included few patients, and none described patients from Israel. We aimed to describe AME patients from Israel and to review the relevant literature...
April 23, 2024: European Journal of Endocrinology
https://read.qxmd.com/read/38652802/predictors-of-treatment-response-in-lymphogenic-metastasized-papillary-thyroid-cancer-a-histopathological-study
#4
JOURNAL ARTICLE
Caroline M J van Kinschot, Lindsey Oudijk, Charlotte van Noord, Tim I M Korevaar, Francien H van Nederveen, Robin P Peeters, Folkert J van Kemenade, W Edward Visser
BACKGROUND: Lymph node metastases in papillary thyroid cancer (PTC) increase the risk for persistent and recurrent disease. Data on the predictive value of histopathological features of lymph node metastases, however, are inconsistent. The aim of this study was to evaluate the prognostic significance of known and new histopathological features of lymph node metastases in a well-defined cohort of PTC patients with clinically evident lymph node metastases. METHODS: A total of 1042 lymph node metastases, derived from 129 PTC patients, were re-examined according to a predefined protocol and evaluated for diameter, extranodal extension, cystic changes, necrosis, calcifications and the proportion of the lymph node taken up by tumor cells...
April 23, 2024: European Journal of Endocrinology
https://read.qxmd.com/read/38652736/increased-mortality-in-acromegaly-is-due-to-vascular-and-respiratory-disease-and-is-normalised-by-control-of-gh-levels-a-retrospective-analysis-from-the-uk-acromegaly-register-1970-2016
#5
JOURNAL ARTICLE
Steve Orme, Richard McNally, Peter W James, Jessica Davis, John Ayuk, Claire Higham, John Wass
CONTEXT: Epidemiological studies involving patients with acromegaly have yielded conflicting results regarding cancer incidence and causes of mortality in relation to control of growth hormone (GH) excess. OBJECTIVE: The objective of this retrospective cohort study is to clarify these questions and identify goals for treatment and monitoring patients. METHODS: We studied 1845 subjects from the UK Acromegaly Register (1970-2016), obtaining cancer standardised incidence rates (SIR) and all causes standardised mortality rates (SMR) from UK Office for National Statistics, to determine the relationship between causes of mortality-age at diagnosis, duration of disease, post-treatment and mean GH levels...
April 23, 2024: Clinical Endocrinology
https://read.qxmd.com/read/38652700/a-rare-case-of-bilateral-frontal-lobe-lesions-due-to-thyroid-storm
#6
JOURNAL ARTICLE
Zhang Delong, Wang Fugui, Hu Xin, Lu Houqing
Thyroid storm is a rare but well-known life-threatening complication that occurs due to acute exacerbation of thyrotoxicosis with the increased levels of circulating thyroid hormones. Reports of metabolic encephalopathy associated with thyroid storm are scarce. We describe the case of a 23-year-old male patient with no previous history of abnormal thyroid function who had consumed excessive amounts of alcohol before disease onset. The patient was found unconscious and febrile on a roadside by a passerby and was admitted to our hospital's emergency department...
April 19, 2024: Archives of Endocrinology and Metabolism
https://read.qxmd.com/read/38652561/comparative-safety-and-effectiveness-of-urea-and-tolvaptan-for-the-management-of-hyponatremia
#7
JOURNAL ARTICLE
Paolo A Scalla, Stephanie M Palma, Erika Dittmar, Francis J Zamora, Estela Trimino
Background: The optimal management of euvolemic and hypervolemic hyponatremia remains controversial. The effectiveness of the vasopressin receptor antagonist tolvaptan on serum sodium normalization has been well described in the literature, although the associated risk of serum sodium overcorrection limits its use. Urea has been proposed as an alternative treatment option due to its milder serum sodium raising effects and adverse event profile. Objective: This study aimed to compare urea and tolvaptan for their serum sodium raising effects and potential for overcorrection...
April 23, 2024: Journal of Pharmacy Practice
https://read.qxmd.com/read/38652425/navigating-breast-cancer-oligometastasis-and-oligoprogression-current-landscape-and-future-directions
#8
REVIEW
Stephanie M Yoon, Jose G Bazan
PURPOSE: We examine the potential for curative approaches among metastatic breast cancer (MBC) patients by exploring the recent literature on local ablative therapies like surgery and stereotactic body radiation therapy (SBRT) in patients with oligometastatic (OM) breast cancer. We also cover therapies for MBC patients with oligoprogressive (OP) disease. KEY FINDINGS: Surgery and SBRT have been studied for OM and OP breast cancer, mainly in retrospective or non-randomized trials...
April 23, 2024: Current Oncology Reports
https://read.qxmd.com/read/38652202/developing-a-novel-enzalutamide-resistant-prostate-cancer-model-via-ar-f877l-mutation-in-lncap-cells
#9
JOURNAL ARTICLE
Ruifeng Wang, Shuhua Ma, Nengwei Xu, Yumiao Gan, Pengya Li, Jingying Zhang, Zhixiang Zhang, Qingyang Gu, Jian Xiang
Prostate cancer is a leading diagnosis and major cause of cancer-related deaths in men worldwide. As a typical hormone-responsive disease, prostate cancer is commonly managed with androgen deprivation therapy (ADT) to curb its progression and potential metastasis. Unfortunately, progression to castration-resistant prostate cancer (CRPC), a notably more aggressive phase of the disease, occurs within a timeframe of 2-3 years following ADT. Enzalutamide, a recognized androgen receptor (AR) antagonist, has been employed as a standard of care for men with metastatic castration-resistant prostate cancer (mCRPC) since it was first approved in 2012, due to its ability to prolong survival...
April 2024: Current protocols
https://read.qxmd.com/read/38651613/the-role-of-phenotypic-plasticity-and-corticosterone-in-coping-with-pond-drying-conditions-in-yellow-bellied-toad-bombina-variegata-linnaeus-1758-tadpoles
#10
JOURNAL ARTICLE
Ana Kijanović, Tanja Vukov, Marko Mirč, Aleksandar Mitrović, Marko D Prokić, Tamara G Petrović, Tijana B Radovanović, Branka R Gavrilović, Svetlana G Despotović, Jelena P Gavrić, Nataša Tomašević Kolarov
Amphibian larvae inhabiting temporary ponds often exhibit the capacity to accelerate development and undergo metamorphosis in challenging conditions like desiccation. However, not all species exhibit this ability, the yellow-bellied toad (Bombina variegata) is one such example. The underlying mechanisms behind the inability to accelerate development under desiccation remain largely unexplored. The hypothalamic-pituitary-interrenal (HPI) axis and corticosterone (CORT), which act synergistically with thyroid hormone, are thought to facilitate metamorphosis in response to desiccation stress...
April 23, 2024: Journal of Experimental Zoology. Part A, Ecological and Integrative Physiology
https://read.qxmd.com/read/38651316/-drastic-changes-in-the-treatment-of-metastatic-prostate-cancer
#11
JOURNAL ARTICLE
Camilla Thellenberg Karlsson, Olof Ståhl
The treatment of metastatic prostate  cancer has seen drastic changes in the recent years with more intense treatment at initial diagnose. The new standard is combination therapy with castration as the backbone and the addition of new hormonal therapies with or without chemotherapy. For patients with minimal metastatic spread it is also recommended to give radiotherapy to the primary tumour. Since many patients now can look forward to longer survival it is paramount to take care of the side-effects of the treatments, where focus is on cardiovascular disease and bone health management...
April 23, 2024: Läkartidningen
https://read.qxmd.com/read/38650837/a-tshr-targeting-aptamer-in-monocytes-correlating-with-clinical-activity-in-tao
#12
JOURNAL ARTICLE
Jiamin Cao, Feng Zhang, Haiyan Chen, Bingxuan Wu, Jiayang Yin, Changci Chenzhao, Wei Xiong
BACKGROUND: Manifestations of thyroid-associated ophthalmopathy (TAO) vary greatly. Few tools and indicators are available to assess TAO, restricting personalized diagnosis and treatment. AIM: To identify an aptamer targeting thyroid-stimulating hormone receptor (TSHR) and utilize this aptamer to evaluate clinical activity in patients with TAO. METHODS: An aptamer targeting TSHR was developed by exponential enrichment and systematic evaluation of TSHR ligands...
2024: International Journal of Nanomedicine
https://read.qxmd.com/read/38650835/unveiling-the-nuances-of-adult-female-acne-a-comprehensive-exploration-of-epidemiology-treatment-modalities-dermocosmetics-and-the-menopausal-influence
#13
REVIEW
Marco Alexandre Dias da Rocha, Markéta Saint Aroman, Valérie Mengeaud, Fabienne Carballido, Gautier Doat, Ana Coutinho, Edileia Bagatin
Previously considered a skin disease exclusively affecting adolescents, characterized by inflammatory and non-inflammatory skin lesions, acne vulgaris is now increasingly observed in adult life, including post-menopause. Today, adult female acne (AFA) is a common chronic inflammatory disease of the pilosebaceous unit, with polymorphic lesions presenting as open or closed comedones, papules, pustules, and even nodules or cysts, often with the presence of sequelae. AFA may persist from adolescence or manifest de novo in adulthood...
2024: International Journal of Women's Health
https://read.qxmd.com/read/38650780/a-surgical-management-of-mediastinal-parathyroid-adenoma-a-regional-experience-in-malaysia
#14
Yen Zhir Tay, Narendran Balasubbiah, Raflis Ruzairee Awang, Benedict Dharmaraj Retna Pandian, Narasimman Sathiamurthy
Primary hyperparathyroidism (PHPT) usually presents with symptoms of hypercalcemia which is due to excessive secretion of parathyroid hormone (PTH). Surgical removal of the secreting tumor either adenoma or hyperplasia remains the mainstay of treatment. Around 2% to 25% of the lesions are located in the mediastinum. We reviewed our institution's surgical treatment and approach to mediastinal parathyroid adenoma (MPA). We retrospectively reviewed the demography, comorbidities, clinical presentation, surgical approach, and outcome for patients in our institution who underwent surgery for MPA from September 2019 until August 2023...
March 2024: Curēus
https://read.qxmd.com/read/38650713/%C3%AE-klotho-levels-in-girls-with-central-precocious-puberty-potential-as-a-diagnostic-and-monitoring-marker
#15
JOURNAL ARTICLE
Jun-Hong Park, Eu-Seon Noh, Il Tae Hwang
BACKGROUND: Recent studies suggest a link between the Klotho protein, sex hormones, and insulin-like growth factor-1 (IGF-1), indicating that α-Klotho levels may rise during puberty, including in central precocious puberty (CPP) cases. This study aimed to explore α-Klotho levels in girls with CPP to assess its potential as a diagnostic and monitoring tool for this condition. METHODS: In total, 139 girls, comprising 82 patients diagnosed with CPP and 57 healthy prepubertal controls, were enrolled in this study...
2024: Frontiers in Endocrinology
https://read.qxmd.com/read/38650398/-treatment-of-non-metastatic-prostate-cancer
#16
JOURNAL ARTICLE
Johan Stranne, Stefan Carlsson, Adalsteinn Gunnlaugsson, Jon Kindblom, Anna Lantz, Ola Bratt
There is a long history of curative treatment of prostate cancer. However, as prostate cancer often grows very slowly, and symptoms do not have time to develop during a person's lifetime, a more tentative approach has become more and more common in many cases. This may be through either watchful waiting or active surveillance. In the first case palliative hormonal treatment is given in the case of progression, in the latter curative treatment would be the choice. When treatment is deemed necessary for localized disease, surgery and radiotherapy are considered equivalent in terms of efficacy and overall risk of side effects...
April 22, 2024: Läkartidningen
https://read.qxmd.com/read/38650100/glucagon-like-peptide-1-new-regulator-in-lipid-metabolism
#17
REVIEW
Tong Bu, Ziyan Sun, Yi Pan, Xia Deng, Guoyue Yuan
Glucagon-like peptide-1 (GLP-1) is a 30-amino acid peptide hormone that is mainly expressed in the intestine and hypothalamus. In recent years, basic and clinical studies have shown that GLP-1 is closely related to lipid metabolism, and it can participate in lipid metabolism by inhibiting fat synthesis, promoting fat differentiation, enhancing cholesterol metabolism, and promoting adipose browning. GLP-1 plays a key role in the occurrence and development of metabolic diseases such as obesity, nonalcoholic fatty liver disease, and atherosclerosis by regulating lipid metabolism...
April 1, 2024: Diabetes & Metabolism Journal
https://read.qxmd.com/read/38650041/pregnancy-and-acromegaly-clinical-outcomes-of-retrospectively-analysed-data-from-the-german-acromegaly-registry
#18
JOURNAL ARTICLE
Anke Tönjes, Marleen Würfel, Marcus Quinkler, Ulrich J Knappe, Jürgen Honegger, Nina Krause-Joppig, Konrad Bacher, Timo Deutschbein, Sylvère Störmann, Jochen Schopohl, Sebastian M Meyhöfer
CONTEXT: Acromegaly is a rare disease caused by excessive growth hormone (GH) secretion, mostly induced by pituitary adenomas. The care of pregnant women with acromegaly is challenging, in part due to existing clinical data being limited and not entirely consistent with regard to potential risks for mother and child. OBJECTIVE: To retrospectively examine data on pregnancy and maternal as well as neonatal outcomes in patients with acromegaly. DESIGN & METHODS: Retrospective data analysis from 47 pregnancies of 31 women treated in centers of the German Acromegaly Registry...
April 22, 2024: Reproductive Biology and Endocrinology: RB&E
https://read.qxmd.com/read/38649821/long-non-coding-rna-sox2ot-in-tamoxifen-resistant-breast-cancer
#19
JOURNAL ARTICLE
Jeeyeon Lee, Eun-Ae Kim, Jieun Kang, Yee Soo Chae, Ho Yong Park, Byeongju Kang, Soo Jung Lee, In Hee Lee, Ji-Young Park, Nora Jee-Young Park, Jin Hyang Jung
Hormone receptor (HR)-positive breast cancer can become aggressive after developing hormone-treatment resistance. This study elucidated the role of long non-coding RNA (lncRNA) SOX2OT in tamoxifen-resistant (TAMR) breast cancer and its potential interplay with the tumor microenvironment (TME). TAMR breast cancer cell lines TAMR-V and TAMR-H were compared with the luminal type A cell line (MCF-7). LncRNA expression was assessed via next-generation sequencing, RNA extraction, lncRNA profiling, and quantitative RT-qPCR...
April 22, 2024: BMC molecular and cell biology
https://read.qxmd.com/read/38649819/key-mrnas-and-lncrnas-of-pituitary-that-affect-the-reproduction-of-fecb%C3%A2-%C3%A2-%C3%A2-small-tail-han-sheep
#20
JOURNAL ARTICLE
Jianqi Yang, Jishun Tang, Xiaoyun He, Ran Di, Xiaosheng Zhang, Jinlong Zhang, Xiaofei Guo, Wenping Hu, Mingxing Chu
BACKGROUND: The pituitary directly regulates the reproductive process through follicle-stimulating hormone (FSH) and luteinizing hormone (LH). Transcriptomic research on the pituitaries of ewes with different FecB (fecundity Booroola) genotypes has shown that some key genes and lncRNAs play an important role in pituitary function and sheep fecundity. Our previous study found that ewes with FecB + + genotypes (without FecB mutation) still had individuals with more than one offspring per birth...
April 22, 2024: BMC Genomics
keyword
keyword
161095
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.